Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity
Development and Application of Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity Among Older Adults
This clinical study aims to develop and apply early-warning and precision-intervention technologies for older adults with declining intrinsic capacity. It intends to identify key digital biomarkers, build dynamic prediction models, and verify the effectiveness of a human-computer interactive adaptive closed-loop intervention system, so as to shift geriatric health management from reactive medical care to proactive health management. The main questions it aims to answer are:
Can multi-modal digital data enable early warning of intrinsic capacity decline among community-dwelling older adults?
Does the AI-driven personalized stepped intervention reduce the incidence of intrinsic capacity decline and adverse health events in older adults?Researchers will compare an integrated whole-course intrinsic-capacity management platform intervention versus routine community-based geriatric health services through a cluster-randomized controlled trial.Participants will:
Complete baseline multi-modal assessments including standard scales and wearable-device-based physiological monitoring Receive follow-up assessments every 3-6 months for 12-24 months in the cohort phase Be assigned to either the intervention group or the control group for a 6-month intervention period Undergo multi-dimensional evaluations at baseline, month 3, month 6 and month 12 Comply with health-management requirements or routine community health services according to group assignment
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Huafang Zhang
- 전화번호: 86-579-89935056
- 이메일: wuyizhangyichi@zju.edu.cn
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Aged 60 years or older
- Residing stably in the affiliated community for at least 6 months
- Conscious and able to cooperate with assessments and device operation (individuals at risk of mild cognitive impairment may participate with assistance)
- Voluntary participation with written informed consent signed
Exclusion Criteria:
- Severe cognitive impairment or acute phase of psychiatric illness, unable to cooperate with assessment or intervention
- Severe heart, lung, liver, or kidney failure, or terminal stage of malignant tumor
- Skin damage, infection, or other conditions affecting wearing of wearable devices
- Judged by the investigator to be unsuitable for participation in the study
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Intervention
Participants receive the Intrinsic Capacity (IC) whole-course management platform intervention for 6 months, with follow-up to 12 months. The intervention includes: (1) an LLM-driven multi-agent AI health coach (knowledge-delivery, empathetic communication, and quality supervision agents); (2) continuous wearable device monitoring (blood pressure, heart rate, activity pattern, sleep architecture, skin temperature, dual-task gait); and (3) risk-stratified, individualized stepped prescriptions covering five domains: nutrition, exercise, cognition, psychological health, and sensory function. The platform collects adherence data in real time and dynamically adjusts the intervention plan (Just-In-Time Adaptive Intervention, JITAI). |
A multi-agent, LLM-driven AI health coach system (knowledge-delivery, empathetic communication, and quality supervision agents) combined with a Just-In-Time Adaptive Intervention (JITAI) decision engine, delivering risk-stratified, individualized stepped interventions across five domains: nutrition, exercise, cognition, psychological health, and sensory function. Delivered for 6 months via the IC whole-course management platform. Wearable devices continuously monitor dynamic blood pressure, heart rate, activity patterns, sleep architecture, skin temperature, and dual-task gait. Device data are uploaded in real time to the platform and used to trigger adaptive, individualized intervention recommendations. |
|
간섭 없음: Control
Participants receive routine community health management services for older adults as usually provided by the community health service center, including regular physical examination and standard health education. Intervention duration is 6 months, with follow-up to 12 months. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of Intrinsic Capacity Decline
기간: From baseline to 12 months
|
The proportion of participants who experience a clinically significant decline in at least one of the five WHO intrinsic capacity domains during follow-up. Each domain is assessed at baseline and at 3, 6, and 12 months using a single prespecified instrument: cognition (MoCA), locomotion (SPPB), psychological status (GDS-15), vitality (MNA-SF), and sensory function (vision and hearing tests). Each instrument is converted against a prespecified threshold into a binary decline judgement (yes/no). These five binary judgements are aggregated into one composite endpoint: a participant is counted as having an event if decline is present in any domain. Only one value is reported, the percentage of participants meeting this composite definition at 12 months, expressed as a percentage of participants. |
From baseline to 12 months
|
|
Incidence of Adverse Health Events
기간: From baseline to 12 months
|
The proportion of participants experiencing at least one event of a composite of adverse health events (falls, emergency department visits, hospitalizations, or death) during follow-up. Each event type is recorded as a binary occurrence and verified against medical records at the 3-, 6-, and 12-month assessments. The four event types are aggregated into a single composite binary endpoint: each participant is counted once if any component event occurs. Only one value is reported, the percentage of participants with at least one component event at 12 months, expressed as a percentage of participants. |
From baseline to 12 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Cognitive Function (MoCA Score)
기간: Baseline to 12 months
|
Change from baseline in the Montreal Cognitive Assessment (MoCA) score at 3, 6, and 12 months. Reported as change in MoCA score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Locomotion (SPPB Score)
기간: Baseline to 12 months
|
Change from baseline in the Short Physical Performance Battery (SPPB) score at 3, 6, and 12 months. Reported as change in SPPB score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Psychological Status (GDS-15 Score)
기간: Baseline to 12 months
|
Change from baseline in the 15-item Geriatric Depression Scale (GDS-15) score at 3, 6, and 12 months. Reported as change in GDS-15 score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Vitality / Nutritional Status (MNA-SF Score)
기간: Baseline to 12 months
|
Change from baseline in the Mini Nutritional Assessment Short-Form (MNA-SF) score at 3, 6, and 12 months. Reported as change in MNA-SF score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Sensory Function Score
기간: Baseline to 12 months
|
Vision and hearing test results are converted according to a prespecified grading rule into a single sensory domain score ranging from 0 to 100. Change from baseline in this sensory domain score is assessed at 3, 6, and 12 months. Reported as change in score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Intrinsic Capacity Digital Index
기간: Baseline to 12 months
|
Change from baseline in the composite Intrinsic Capacity Digital Index (0-10), derived by aggregating multimodal wearable and assessment data at 3, 6, and 12 months. Reported as change in index score points; only one value is reported. |
Baseline to 12 months
|
공동 작업자 및 조사자
스폰서
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- KY-2026-0221
- No.2026C02A1144 (기타 식별자: Key R&D Program of Zhejiang)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .